CrossrefInfokarte
Napabucasin Plus FOLFIRI in Patients With Previously Treated Metastatic Colorectal Cancer: Results From the Open-Label, Randomized Phase III CanStem303C Study
Clinical Colorectal Cancer · 2023-03 · 22 (1) · 100-110
DOI: 10.1016/j.clcc.2022.11.002 ↗Abstract
Kein Abstract verfügbar.
EUVIMED